A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Induction and maintenance of peripheral tolerance are important mechanisms to maintain the balance of the immune system. In addition to the deletion of T cells and their failure to respond in certain circumstances, active suppression mediated by T cells or T-cell factors has been proposed as a mechanism for maintaining peripheral tolerance. However, the inability to isolate and clone regulatory T cells involved in antigen-specific inhibition of immune responses has made it difficult to understand the mechanisms underlying such active suppression. Here we show that chronic activation of both human and murine CD4+T cells in the presence of interleukin (IL)-10 gives rise to CD4+T-cell clones with low proliferative capacity, producing high levels of IL-10, low levels of IL-2 and no IL-4. These antigen-specific T-cell clones suppress the proliferation of CD4+T cells in response to antigen, and prevent colitis induced in SCID mice by pathogenic CD4+CD45RBhighsplenic T cells. Thus IL-10 drives the generation of a CD4+T-cell subset, designated T regulatory cells 1 (Tr1), which suppresses antigen-specific immune responses and actively downregulates a pathological immune response in vivo .

[1]  R. Schwartz,et al.  A cell culture model for T lymphocyte clonal anergy. , 1990, Science.

[2]  G. Nossal Bone marrow pre-B cells and the clonal anergy theory of immunologic tolerance. , 1987, International reviews of immunology.

[3]  R. de Waal Malefyt,et al.  High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.

[4]  M. Lotze,et al.  Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors , 1995, The Journal of experimental medicine.

[5]  R. Gorczynski,et al.  A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. , 1994, Journal of immunology.

[6]  R. Germain,et al.  A Single Major Pathway of T‐Lymphocyte Interactions in Antigen‐Specific Immune Suppression , 1981, Scandinavian journal of immunology.

[7]  W. V. van Blitterswijk,et al.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.

[8]  B. Rocha,et al.  Peripheral selection of the T cell repertoire. , 1991, Science.

[9]  S. Smith,et al.  Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. , 1995, Blood.

[10]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[11]  K. Murphy,et al.  Reversibility of T helper 1 and 2 populations is lost after long-term stimulation , 1996, The Journal of experimental medicine.

[12]  T. Honjo,et al.  Administration of interleukin ‐5 or ‐10 activates peritoneal B‐1 cells and induces autoimmune hemolytic anemia in anti‐erythrocyte autoantibody‐transgenic mice , 1995, European journal of immunology.

[13]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[14]  K. Murphy,et al.  Role of cytokines in development of Th1 and Th2 cells. , 1996, Chemical Immunology.

[15]  J. Becker,et al.  Maintenance of clonal anergy by endogenously produced IL-10. , 1994, International immunology.

[16]  H. Weiner,et al.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.

[17]  N. Sarvetnick,et al.  Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. , 1994, The Journal of clinical investigation.

[18]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[19]  C. Brosnan,et al.  IL‐10 fails to abrogate experimental autoimmune encephalomyelitis , 1996, Journal of neuroscience research.

[20]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[21]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[22]  J. D. de Vries,et al.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells , 1996, The Journal of experimental medicine.

[23]  C. Sidman,et al.  Differential cytokine expression in acute and chronic murine graft‐versus‐host‐disease , 1993, European journal of immunology.

[24]  D. Abramowicz,et al.  Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. , 1993, Transplantation proceedings.

[25]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[26]  R. Kühn,et al.  Interleukin-10 Deficient Mice , 1995 .

[27]  H. Jun,et al.  A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. , 1996, Journal of autoimmunity.

[28]  R. Schwartz,et al.  Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. , 1990, Journal of immunology.

[29]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.